PRIMO 2024 | Multidisciplinary approaches in treating brain tumors: current landscape and future directions

Glenn Lesser, MD, from Wake Forest School of Medicine in Winston-Salem, NC, discusses the multidisciplinary nature of treating malignant brain tumors, highlighting the continued role of radiation, chemotherapy, and surgery alongside emerging non-cytotoxic therapies. He explores the potential of therapies that stimulate the immune system while releasing tumor antigens, emphasizing the need for targeted approaches to spare normal brain tissue. Prof. Lesser anticipates combinatorial and multimodal therapies as the future direction, acknowledging successes with targeted therapies but underscoring the complexity of treating common brain tumors like glioblastoma. This interview took place at the 2024 PRIMO meeting in Honolulu, Hawaii.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.